Industry Research Reports

Home > Reports > Service & Software > Viral Inactivation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Viral Inactivation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-07-15

Pages: 120 Pages

Report ld: 6973140

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Viral Inactivation Market Size(US$)

CAGR 2026-2032

10.1%

Market Size,2032

USD 1,283

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 722 million

Market Forecast in 2032(Value)

US$ 1,283 million

CAGR

10.1%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Viral Inactivation was estimated to be worth US$ 662 million in 2025 and is projected to reach US$ 1283 million, growing at a CAGR of 10.1% from 2026 to 2032.

Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.

Estimates of their viral inactivation market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

This report provides a comprehensive view of the global market for Viral Inactivation, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Viral Inactivation market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Viral Inactivation.

MARKET SEGMENTATION

By Company

Danaher
Merck
Parker Hannifin
Sartorius
SGS
Charles River Laboratories International
Clean Cells
Rad Source Technologies
Texcell
Viral Inactivated Plasma Systems
Wuxi Pharmatech (Cayman)

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Kits and Reagents
Services
Viral Inactivation Systems and Accessories

Segment by Application

Blood and Blood Products
Cellular and Gene Therapy Products
Stem Cell Products
Tissue and Tissue Products
Vaccines and Therapeutics

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Viral Inactivation companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Viral Inactivation revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Viral Inactivation revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Viral Inactivation Product Introduction

1.2 Global Viral Inactivation Market Size Forecast (2021–2032)

1.3 Viral Inactivation Market Trends & Drivers

1.3.1 Viral Inactivation Industry Trends

1.3.2 Viral Inactivation Market Drivers & Opportunities

1.3.3 Viral Inactivation Market Challenges

1.3.4 Viral Inactivation Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Viral Inactivation Players Revenue Ranking (2025)

2.2 Global Viral Inactivation Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Viral Inactivation Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Viral Inactivation

2.6 Viral Inactivation Market Competitive Analysis

2.6.1 Viral Inactivation Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Viral Inactivation Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Viral Inactivation revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Viral Inactivation Market Classification

3.1 Introduction by Type

3.1.1 Kits and Reagents

3.1.2 Services

3.1.3 Viral Inactivation Systems and Accessories

3.1.4 Global Viral Inactivation Sales Value by Type

3.1.4.1 Global Viral Inactivation Sales Value by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Viral Inactivation Sales Value, by Type (2021–2032)

3.1.4.3 Global Viral Inactivation Sales Value, by Type (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Blood and Blood Products

4.1.2 Cellular and Gene Therapy Products

4.1.3 Stem Cell Products

4.1.4 Tissue and Tissue Products

4.1.5 Vaccines and Therapeutics

4.2 Global Viral Inactivation Sales Value by Application

4.2.1 Global Viral Inactivation Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Viral Inactivation Sales Value by Application (2021–2032)

4.2.3 Global Viral Inactivation Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Viral Inactivation Sales Value by Region

5.1.1 Global Viral Inactivation Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Viral Inactivation Sales Value by Region (2021–2026)

5.1.3 Global Viral Inactivation Sales Value by Region (2027–2032)

5.1.4 Global Viral Inactivation Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Viral Inactivation Sales Value, 2021–2032

5.2.2 North America Viral Inactivation Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Viral Inactivation Sales Value, 2021–2032

5.3.2 Europe Viral Inactivation Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Viral Inactivation Sales Value, 2021–2032

5.4.2 Asia Pacific Viral Inactivation Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Viral Inactivation Sales Value, 2021–2032

5.5.2 South America Viral Inactivation Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Viral Inactivation Sales Value, 2021–2032

5.6.2 Middle East & Africa Viral Inactivation Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Viral Inactivation Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Viral Inactivation Sales Value, 2021–2032

6.3 United States

6.3.1 United States Viral Inactivation Sales Value, 2021–2032

6.3.2 United States Viral Inactivation Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Viral Inactivation Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Viral Inactivation Sales Value, 2021–2032

6.4.2 Europe Viral Inactivation Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Viral Inactivation Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Viral Inactivation Sales Value, 2021–2032

6.5.2 China Viral Inactivation Sales Value by Type (%), 2025 vs 2032

6.5.3 China Viral Inactivation Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Viral Inactivation Sales Value, 2021–2032

6.6.2 Japan Viral Inactivation Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Viral Inactivation Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Viral Inactivation Sales Value, 2021–2032

6.7.2 South Korea Viral Inactivation Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Viral Inactivation Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Viral Inactivation Sales Value, 2021–2032

6.8.2 Southeast Asia Viral Inactivation Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Viral Inactivation Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Viral Inactivation Sales Value, 2021–2032

6.9.2 India Viral Inactivation Sales Value by Type (%), 2025 vs 2032

6.9.3 India Viral Inactivation Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Danaher

7.1.1 Danaher Profile

7.1.2 Danaher Main Business

7.1.3 Danaher Viral Inactivation Products, Services, and Solutions

7.1.4 Danaher Viral Inactivation Revenue (US$ Million), 2021–2026

7.1.5 Danaher Recent Developments

7.2 Merck

7.2.1 Merck Profile

7.2.2 Merck Main Business

7.2.3 Merck Viral Inactivation Products, Services, and Solutions

7.2.4 Merck Viral Inactivation Revenue (US$ Million), 2021–2026

7.2.5 Merck Recent Developments

7.3 Parker Hannifin

7.3.1 Parker Hannifin Profile

7.3.2 Parker Hannifin Main Business

7.3.3 Parker Hannifin Viral Inactivation Products, Services, and Solutions

7.3.4 Parker Hannifin Viral Inactivation Revenue (US$ Million), 2021–2026

7.3.5 Parker Hannifin Recent Developments

7.4 Sartorius

7.4.1 Sartorius Profile

7.4.2 Sartorius Main Business

7.4.3 Sartorius Viral Inactivation Products, Services, and Solutions

7.4.4 Sartorius Viral Inactivation Revenue (US$ Million), 2021–2026

7.4.5 Sartorius Recent Developments

7.5 SGS

7.5.1 SGS Profile

7.5.2 SGS Main Business

7.5.3 SGS Viral Inactivation Products, Services, and Solutions

7.5.4 SGS Viral Inactivation Revenue (US$ Million), 2021–2026

7.5.5 SGS Recent Developments

7.6 Charles River Laboratories International

7.6.1 Charles River Laboratories International Profile

7.6.2 Charles River Laboratories International Main Business

7.6.3 Charles River Laboratories International Viral Inactivation Products, Services, and Solutions

7.6.4 Charles River Laboratories International Viral Inactivation Revenue (US$ Million), 2021–2026

7.6.5 Charles River Laboratories International Recent Developments

7.7 Clean Cells

7.7.1 Clean Cells Profile

7.7.2 Clean Cells Main Business

7.7.3 Clean Cells Viral Inactivation Products, Services, and Solutions

7.7.4 Clean Cells Viral Inactivation Revenue (US$ Million), 2021–2026

7.7.5 Clean Cells Recent Developments

7.8 Rad Source Technologies

7.8.1 Rad Source Technologies Profile

7.8.2 Rad Source Technologies Main Business

7.8.3 Rad Source Technologies Viral Inactivation Products, Services, and Solutions

7.8.4 Rad Source Technologies Viral Inactivation Revenue (US$ Million), 2021–2026

7.8.5 Rad Source Technologies Recent Developments

7.9 Texcell

7.9.1 Texcell Profile

7.9.2 Texcell Main Business

7.9.3 Texcell Viral Inactivation Products, Services, and Solutions

7.9.4 Texcell Viral Inactivation Revenue (US$ Million), 2021–2026

7.9.5 Texcell Recent Developments

7.10 Viral Inactivated Plasma Systems

7.10.1 Viral Inactivated Plasma Systems Profile

7.10.2 Viral Inactivated Plasma Systems Main Business

7.10.3 Viral Inactivated Plasma Systems Viral Inactivation Products, Services, and Solutions

7.10.4 Viral Inactivated Plasma Systems Viral Inactivation Revenue (US$ Million), 2021–2026

7.10.5 Viral Inactivated Plasma Systems Recent Developments

7.11 Wuxi Pharmatech (Cayman)

7.11.1 Wuxi Pharmatech (Cayman) Profile

7.11.2 Wuxi Pharmatech (Cayman) Main Business

7.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Products, Services, and Solutions

7.11.4 Wuxi Pharmatech (Cayman) Viral Inactivation Revenue (US$ Million), 2021–2026

7.11.5 Wuxi Pharmatech (Cayman) Recent Developments

8 Industry Chain Analysis

8.1 Viral Inactivation Value Chain

8.2 Viral Inactivation Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Viral Inactivation Sales Model

8.5.2 Sales Channels

8.5.3 Viral Inactivation Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Viral Inactivation Market Trends

Table 2. Viral Inactivation Market Drivers & Opportunities

Table 3. Viral Inactivation Market Challenges

Table 4. Viral Inactivation Market Restraints

Table 5. Global Viral Inactivation Revenue by Company (US$ Million), 2021–2026

Table 6. Global Viral Inactivation Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Viral Inactivation Product Type

Table 9. Key Companies General Availability (GA) Timeline for Viral Inactivation

Table 10. Global Viral Inactivation Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Viral Inactivation revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Viral Inactivation Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Viral Inactivation Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Viral Inactivation Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Viral Inactivation Sales Market Share in Value by Type (2021–2026)

Table 17. Global Viral Inactivation Sales Market Share in Value by Type (2027–2032)

Table 18. Global Viral Inactivation Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Viral Inactivation Sales Value by Application (US$ Million), 2021–2026

Table 20. Global Viral Inactivation Sales Value by Application (US$ Million), 2027–2032

Table 21. Global Viral Inactivation Sales Market Share in Value by Application (2021–2026)

Table 22. Global Viral Inactivation Sales Market Share in Value by Application (2027–2032)

Table 23. Global Viral Inactivation Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 24. Global Viral Inactivation Sales Value by Region (US$ Million), 2021–2026

Table 25. Global Viral Inactivation Sales Value by Region (US$ Million), 2027–2032

Table 26. Global Viral Inactivation Sales Value by Region (%), 2021–2026

Table 27. Global Viral Inactivation Sales Value by Region (%), 2027–2032

Table 28. Key Countries/Regions Viral Inactivation Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 29. Key Countries/Regions Viral Inactivation Sales Value, (US$ Million), 2021–2026

Table 30. Key Countries/Regions Viral Inactivation Sales Value, (US$ Million), 2027–2032

Table 31. Danaher Basic Information List

Table 32. Danaher Description and Business Overview

Table 33. Danaher Viral Inactivation Products, Services, and Solutions

Table 34. Revenue (US$ Million) in Viral Inactivation Business of Danaher (2021–2026)

Table 35. Danaher Recent Developments

Table 36. Merck Basic Information List

Table 37. Merck Description and Business Overview

Table 38. Merck Viral Inactivation Products, Services, and Solutions

Table 39. Revenue (US$ Million) in Viral Inactivation Business of Merck (2021–2026)

Table 40. Merck Recent Developments

Table 41. Parker Hannifin Basic Information List

Table 42. Parker Hannifin Description and Business Overview

Table 43. Parker Hannifin Viral Inactivation Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Viral Inactivation Business of Parker Hannifin (2021–2026)

Table 45. Parker Hannifin Recent Developments

Table 46. Sartorius Basic Information List

Table 47. Sartorius Description and Business Overview

Table 48. Sartorius Viral Inactivation Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Viral Inactivation Business of Sartorius (2021–2026)

Table 50. Sartorius Recent Developments

Table 51. SGS Basic Information List

Table 52. SGS Description and Business Overview

Table 53. SGS Viral Inactivation Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Viral Inactivation Business of SGS (2021–2026)

Table 55. SGS Recent Developments

Table 56. Charles River Laboratories International Basic Information List

Table 57. Charles River Laboratories International Description and Business Overview

Table 58. Charles River Laboratories International Viral Inactivation Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Viral Inactivation Business of Charles River Laboratories International (2021–2026)

Table 60. Charles River Laboratories International Recent Developments

Table 61. Clean Cells Basic Information List

Table 62. Clean Cells Description and Business Overview

Table 63. Clean Cells Viral Inactivation Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Viral Inactivation Business of Clean Cells (2021–2026)

Table 65. Clean Cells Recent Developments

Table 66. Rad Source Technologies Basic Information List

Table 67. Rad Source Technologies Description and Business Overview

Table 68. Rad Source Technologies Viral Inactivation Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Viral Inactivation Business of Rad Source Technologies (2021–2026)

Table 70. Rad Source Technologies Recent Developments

Table 71. Texcell Basic Information List

Table 72. Texcell Description and Business Overview

Table 73. Texcell Viral Inactivation Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Viral Inactivation Business of Texcell (2021–2026)

Table 75. Texcell Recent Developments

Table 76. Viral Inactivated Plasma Systems Basic Information List

Table 77. Viral Inactivated Plasma Systems Description and Business Overview

Table 78. Viral Inactivated Plasma Systems Viral Inactivation Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Viral Inactivation Business of Viral Inactivated Plasma Systems (2021–2026)

Table 80. Viral Inactivated Plasma Systems Recent Developments

Table 81. Wuxi Pharmatech (Cayman) Basic Information List

Table 82. Wuxi Pharmatech (Cayman) Description and Business Overview

Table 83. Wuxi Pharmatech (Cayman) Viral Inactivation Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Viral Inactivation Business of Wuxi Pharmatech (Cayman) (2021–2026)

Table 85. Wuxi Pharmatech (Cayman) Recent Developments

Table 86. Revenue (US$ Million) in Viral Inactivation Business of Company 40 (2021–2026)

Table 87. Company 40 Recent Developments

Table 88. Key Raw Materials Lists

Table 89. Key Suppliers of Raw Materials Lists

Table 90. Viral Inactivation Downstream Customers

Table 91. Viral Inactivation Distributors List

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

List of Figures

Figure 1. Viral Inactivation Product Picture

Figure 2. Global Viral Inactivation Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Viral Inactivation Sales Value (US$ Million), 2021–2032

Figure 4. Viral Inactivation Report Years Considered

Figure 5. Global Viral Inactivation Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Viral Inactivation Revenue in 2025

Figure 7. Viral Inactivation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Kits and Reagents Picture

Figure 9. Services Picture

Figure 10. Viral Inactivation Systems and Accessories Picture

Figure 11. Global Viral Inactivation Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Viral Inactivation Sales Value Market Share by Type, 2025 & 2032

Figure 13. Product Picture of Blood and Blood Products

Figure 14. Product Picture of Cellular and Gene Therapy Products

Figure 15. Product Picture of Stem Cell Products

Figure 16. Product Picture of Tissue and Tissue Products

Figure 17. Product Picture of Vaccines and Therapeutics

Figure 18. Global Viral Inactivation Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 19. Global Viral Inactivation Sales Value Market Share by Application, 2025 & 2032

Figure 20. North America Viral Inactivation Sales Value (US$ Million), 2021–2032

Figure 21. North America Viral Inactivation Sales Value by Country (%), 2025 vs 2032

Figure 22. Europe Viral Inactivation Sales Value (US$ Million), 2021–2032

Figure 23. Europe Viral Inactivation Sales Value by Country (%), 2025 vs 2032

Figure 24. Asia Pacific Viral Inactivation Sales Value (US$ Million), 2021–2032

Figure 25. Asia Pacific Viral Inactivation Sales Value by Subregion (%), 2025 vs 2032

Figure 26. South America Viral Inactivation Sales Value (US$ Million), 2021–2032

Figure 27. South America Viral Inactivation Sales Value by Country (%), 2025 vs 2032

Figure 28. Middle East & Africa Viral Inactivation Sales Value (US$ Million), 2021–2032

Figure 29. Middle East & Africa Viral Inactivation Sales Value by Country (%), 2025 vs 2032

Figure 30. Key Countries/Regions Viral Inactivation Sales Value (%), 2021–2032

Figure 31. United States Viral Inactivation Sales Value (US$ Million), 2021–2032

Figure 32. United States Viral Inactivation Sales Value by Type (%), 2025 vs 2032

Figure 33. United States Viral Inactivation Sales Value by Application (%), 2025 vs 2032

Figure 34. Europe Viral Inactivation Sales Value (US$ Million), 2021–2032

Figure 35. Europe Viral Inactivation Sales Value by Type (%), 2025 vs 2032

Figure 36. Europe Viral Inactivation Sales Value by Application (%), 2025 vs 2032

Figure 37. China Viral Inactivation Sales Value (US$ Million), 2021–2032

Figure 38. China Viral Inactivation Sales Value by Type (%), 2025 vs 2032

Figure 39. China Viral Inactivation Sales Value by Application (%), 2025 vs 2032

Figure 40. Japan Viral Inactivation Sales Value (US$ Million), 2021–2032

Figure 41. Japan Viral Inactivation Sales Value by Type (%), 2025 vs 2032

Figure 42. Japan Viral Inactivation Sales Value by Application (%), 2025 vs 2032

Figure 43. South Korea Viral Inactivation Sales Value (US$ Million), 2021–2032

Figure 44. South Korea Viral Inactivation Sales Value by Type (%), 2025 vs 2032

Figure 45. South Korea Viral Inactivation Sales Value by Application (%), 2025 vs 2032

Figure 46. Southeast Asia Viral Inactivation Sales Value (US$ Million), 2021–2032

Figure 47. Southeast Asia Viral Inactivation Sales Value by Type (%), 2025 vs 2032

Figure 48. Southeast Asia Viral Inactivation Sales Value by Application (%), 2025 vs 2032

Figure 49. India Viral Inactivation Sales Value (US$ Million), 2021–2032

Figure 50. India Viral Inactivation Sales Value by Type (%), 2025 vs 2032

Figure 51. India Viral Inactivation Sales Value by Application (%), 2025 vs 2032

Figure 52. Viral Inactivation Value Chain

Figure 53. Viral Inactivation Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Viral Inactivation in 2026? zhanKai

The global market size of Viral Inactivation in 2026 was 722 Million USD.

What was the global market size of Viral Inactivation in 2032? shouQi

What is the annual compound growth rate of the global Viral Inactivation market size from 2026 to 2032? shouQi

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Viral Inactivation market? shouQi

Related Reports

Global Viral Inactivation Market Research Report 2026
The global Viral Inactivation market was valued at US$ 662 million in 2025 and is anticipated to reach US$ 1283 million by 2032, at a CAGR of 10.1% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 117
USD 2900.00
(Single User License)
Global Viral Inactivation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Viral Inactivation market size was US$ 607 million in 2024 and is forecast to a readjusted size of US$ 1177 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 91
USD 4250.00
(Single User License)
Global Viral Inactivation Market Research Report 2025
The global market for Viral Inactivation was valued at US$ 607 million in the year 2024 and is projected to reach a revised size of US$ 1177 million by 2031, growing at a CAGR of 10.1% during the forecast period.
Published Date: 2025-02-27
Pages: 83
USD 2900.00
(Single User License)
Viral Inactivation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Viral Inactivation was estimated to be worth US$ 607 million in 2024 and is forecast to a readjusted size of US$ 1177 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 112
USD 3950.00
(Single User License)
Global Viral Inactivation Market Insights, Forecast to 2030
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Published Date: 2024-04-25
Pages: 106
USD 4900.00
(Single User License)
Global Viral Inactivation Market Research Report 2024
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Published Date: 2024-01-11
Pages: 84
USD 2900.00
(Single User License)

Global Viral Inactivation Market Research Report 2026
The global Viral Inactivation market was valued at US$ 662 million in 2025 and is anticipated to reach US$ 1283 million by 2032, at a CAGR of 10.1% from 2026 to 2032.
Published: 2026-04-28
Pages: 117
USD 2900.00 (Single User License)
Global Viral Inactivation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Viral Inactivation market size was US$ 607 million in 2024 and is forecast to a readjusted size of US$ 1177 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 91
USD 4250.00 (Single User License)
Global Viral Inactivation Market Research Report 2025
The global market for Viral Inactivation was valued at US$ 607 million in the year 2024 and is projected to reach a revised size of US$ 1177 million by 2031, growing at a CAGR of 10.1% during the forecast period.
Published: 2025-02-27
Pages: 83
USD 2900.00 (Single User License)
Viral Inactivation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Viral Inactivation was estimated to be worth US$ 607 million in 2024 and is forecast to a readjusted size of US$ 1177 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 112
USD 3950.00 (Single User License)
Global Viral Inactivation Market Insights, Forecast to 2030
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Published: 2024-04-25
Pages: 106
USD 4900.00 (Single User License)
Global Viral Inactivation Market Research Report 2024
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Published: 2024-01-11
Pages: 84
USD 2900.00 (Single User License)